Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

Source:http://linkedlifedata.com/resource/pubmed/id/17136357

Download in:

View as

General Info

PMID
17136357